What are the side effects of Lenapavir Sodium/Salanca?

Lenapavir/Sunlenca treatment (AIDS) was generally well tolerated, with most patients experiencing mild to moderate adverse effects that could be alleviated with supportive care. The most common clinical side effects are injection site reactions, including pain, redness, swelling, itching or induration, which generally resolve spontaneously within a few days. This type of reaction is a local inflammatory reaction caused by the drug's sustained release mechanism and does not affect the long-term efficacy.

In terms of systemic adverse reactions, some patients may experience mild fatigue, headache, nausea or loss of appetite, which is related to the long-term metabolism of the drug. Mild increases in liver enzymes or bilirubin may be seen in individual cases, but most can recover without stopping the drug. Doctors usually recommend close monitoring of liver function and blood sugar indicators in the early stages of treatment to ensure safety.

In addition, since lenapavir sodium mainly inhibits the viral capsid rather than affecting the human metabolic system, it will not cause significant hormonal or bone metabolism disorders. This is a major improvement compared with some older HIV drugs. For injectable drugs, patients are advised to keep the injection site clean and avoid hard friction or hot compresses to reduce local irritation.

Clinical experience shows that lenapavir sodium has good long-term drug safety. After drug withdrawal, the drug is cleared slowly and the blood concentration is maintained for a long time, which further enhances the persistence of its treatment. When used in combination with other long-acting HIV drugs, doctors will adjust the dosage and monitoring plan based on the patient's individual conditions.

In general, lenapavir sodium, as the world's first long-acting HIV capsid inhibitor injected once every six months, has controllable side effects and high safety, and represents the latest achievement in the development of precision and low-burden HIV treatment. For patients who have been living with the virus for a long time, it not only brings new treatment options, but also means a significant improvement in quality of life and psychological burden.

Reference materials:https://www.drugs.com/sunlenca.html